abstract |
The present invention relates to Nox4 inhibitors, their pharmaceutical compositions and their use for the treatment and / or prevention of osteoporosis or osteoclast differentiation dysfunction, in particular, osteoporotic and osteoblastic osteoclast differentiation dysfunction. |